Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis
Laura Dumitrescu, Αθανάσιος Παπαθανασίου, Catalina Coclitu, et al.
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 4, pp. 495-509
Open Access | Times Cited: 21

Showing 21 citing articles:

Sphingosine 1‐phosphate receptor modulators in multiple sclerosis treatment: A practical review
Patricia K. Coyle, Mark S. Freedman, Bruce A. Cohen, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 4, pp. 842-855
Open Access | Times Cited: 10
Immune System Dysregulation in the Progression of Multiple Sclerosis: Molecular Insights and Therapeutic Implications
Zuber Khan, Sidharth Mehan, Ghanshyam Das Gupta, et al.
Neuroscience (2024) Vol. 548, pp. 9-26
Closed Access | Times Cited: 7
Investigating Treatment Alternatives for Fingolimod in Patients with Multiple Sclerosis Developed Refractory Fingolimod-Related Genital Human Papilloma Virus (HPV) Infection
Sepideh Paybast, Fereshteh Ashtari, Nahid Beladi Moghaddam, et al.
Multiple Sclerosis and Related Disorders (2025), pp. 106284-106284
Closed Access
Sphingosine 1-phosphate signaling during infection and immunity
Sabira Mohammed, A. R. Bindu, Viswanathan Arun, et al.
Progress in Lipid Research (2023) Vol. 92, pp. 101251-101251
Closed Access | Times Cited: 15
Update on fungal lipid biosynthesis inhibitors as antifungal agents
Monika Vishwakarma, Tanweer Haider, Vandana Soni
Microbiological Research (2023) Vol. 278, pp. 127517-127517
Closed Access | Times Cited: 13
The role of sphingosine-1-phosphate in autophagy and related disorders
Siqi Xiao, Kaixin Peng, C.-L. Li, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Expert opinion on the use of contraception in people with multiple sclerosis
Jan Hillert, Riley Bove, Lisa B. Haddad, et al.
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 9, pp. 1093-1106
Open Access | Times Cited: 3
The Oncogenic Lipid Sphingosine-1-Phosphate Impedes the Phagocytosis of Tumor Cells by M1 Macrophages in Diffuse Large B Cell Lymphoma
Tracey Perry, Navta Masand, Katerina Vrzalikova, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 574-574
Open Access | Times Cited: 2
Targeting Sphingosine 1-Phosphate Metabolism as a Therapeutic Avenue for Prostate Cancer
Saïda Mebarek, Najwa Skafi, Leyre Brizuela
Cancers (2023) Vol. 15, Iss. 10, pp. 2732-2732
Open Access | Times Cited: 5
Hunger guides immunity to friend versus foe
Noga Or‐Geva, Lawrence Steinman
Nature Neuroscience (2024) Vol. 27, Iss. 3, pp. 393-394
Closed Access | Times Cited: 1
Can treatment adverse events be optimized by switching between different sphingosine 1-phosphate receptor modulators in multiple sclerosis? A case series
Simone Guerrieri, Martina Rubin, Irene Gattuso, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3678-3681
Closed Access | Times Cited: 1
Evaluation of proximod, a selective agonist of sphingosine-1-phosphate receptor-1, in healthy volunteers and patients with rheumatoid arthritis: a phase 1, double-blind, randomised, placebo-controlled, ascending dose trial
Hong Zhang, Qianqian Li, Cuiyun Li, et al.
The Lancet Rheumatology (2024)
Closed Access | Times Cited: 1
In Silico Analysis of Individual Fractions of Bovine Casein as Precursors of Bioactive Peptides—Influence of Post-Translational Modifications
Piotr Mińkiewicz, Małgorzata Darewicz, Anna Iwaniak
Applied Sciences (2023) Vol. 13, Iss. 14, pp. 8091-8091
Open Access | Times Cited: 4
Unraveling the Role of the Glycogen Synthase Kinase-3β, Bruton’s Tyrosine Kinase, and Sphingosine 1 Phosphate Pathways in Multiple Sclerosis
Rupali Mohite, Sankalp Gharat, Gaurav Doshi
Endocrine Metabolic & Immune Disorders - Drug Targets (2024) Vol. 24, Iss. 10, pp. 1131-1145
Closed Access
Effects of High Efficacy Multiple Sclerosis Disease Modifying Drugs on the Immune Synapse: A Systematic Review
Spyros Deftereos, George D. Vavougios, Christos Bakirtzis, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 7, pp. 536-551
Closed Access
Potential adverse events associated with sphingosine-1-phosphate (S1P) receptor modulators in patients with multiple sclerosis: an analysis of the FDA adverse event reporting system (FAERS) database
Xiping Yang, Yan Yan, Suyao Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
T cell trafficking in human chronic inflammatory diseases
Anna Giovenzana, Valentina Codazzi, Michele Pandolfo, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110528-110528
Open Access
Decoding multiple sclerosis: Unravelling the complexities of pathogenesis, progression, mechanisms and therapeutic innovations
Syeda Rida Zainab, Jehanzeb Khan, Muhammad Khalid Tipu, et al.
Neuroscience (2024)
Closed Access
Real-world data on siponimod-related lymphopenia among people with secondary progressive multiple sclerosis
Christopher Gilmartin, Natasha Hoyle, Afagh Garjani, et al.
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 4-5, pp. 600-604
Closed Access
Disease-modifying therapy in patients with multiple sclerosis and a coexisting autoimmune disease
Dariusz Dziubek, Karolina Dziubek
Aktualności Neurologiczne (2024) Vol. 24, Iss. 3, pp. 106-113
Open Access
Topical Collection: New Insights on Sphingolipids in Health and Disease
Andrea Huwiler
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9528-9528
Open Access | Times Cited: 1
Peripheral immune system modulates Purkinje cell degeneration in Niemann–Pick disease type C1
Toru Yasuda, Toru Uchiyama, Nobuyuki Watanabe, et al.
Life Science Alliance (2023) Vol. 6, Iss. 9, pp. e202201881-e202201881
Open Access
Page 1

Scroll to top